Literature DB >> 23291607

Compensatory increase in USP14 activity accompanies impaired proteasomal proteolysis during aging.

Subramaniam Ponnappan1, Michela Palmieri, Dennis H Sullivan, Usha Ponnappan.   

Abstract

The deubiquitinating enzyme, USP14, found in association with the proteasome is essential in mediating ubiquitin trimming and in ensuring ubiquitin-homeostasis. As aging is accompanied by a significant decline in proteasomal proteolysis in primary human T lymphocytes, we evaluated the contributory role of USP14 in this decline. Our studies for the first time demonstrate that enzymatic activity of proteasome-associated USP14 is significantly higher in T cells obtained from elderly donors. Additionally, such an increase in USP14 activity could be mimicked by chemically inhibiting the proteasome, using lactacystin. Thus, USP14 activity appears to be reciprocally regulated by the catalytic function of the 26S proteasome. To determine whether the inhibition of USP14 activity counter regulates proteasomal proteolysis, T cells pretreated with a small molecule inhibitor of USP14, IU1, were activated and assessed for IκBα degradation as a measure of proteasomal proteolysis. While T cells obtained from young donors demonstrated increased degradation of IκBα, those from the elderly remained unaffected by IU1 pretreatment. Taken together, these results demonstrate that the decrease in proteolysis of proteasomal substrates during aging is independent of the increased USP14 activity and that the reciprocal regulation of USP14 and proteasomal catalytic activity may be necessary to maintain cellular ubiquitin homeostasis.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23291607      PMCID: PMC3558606          DOI: 10.1016/j.mad.2012.12.007

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  26 in total

1.  A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14.

Authors:  A Borodovsky; B M Kessler; R Casagrande; H S Overkleeft; K D Wilkinson; H L Ploegh
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

2.  Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome.

Authors:  Rati Verma; L Aravind; Robert Oania; W Hayes McDonald; John R Yates; Eugene V Koonin; Raymond J Deshaies
Journal:  Science       Date:  2002-08-15       Impact factor: 47.728

Review 3.  Aging and immune function: molecular mechanisms to interventions.

Authors:  Subramaniam Ponnappan; Usha Ponnappan
Journal:  Antioxid Redox Signal       Date:  2011-01-08       Impact factor: 8.401

Review 4.  Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes.

Authors:  Min Jae Lee; Byung-Hoon Lee; John Hanna; Randall W King; Daniel Finley
Journal:  Mol Cell Proteomics       Date:  2010-09-07       Impact factor: 5.911

Review 5.  Assembly, structure, and function of the 26S proteasome.

Authors:  Lynn Bedford; Simon Paine; Paul W Sheppard; R John Mayer; Jeroen Roelofs
Journal:  Trends Cell Biol       Date:  2010-04-26       Impact factor: 20.808

6.  Ubiquitinated proteins activate the proteasome by binding to Usp14/Ubp6, which causes 20S gate opening.

Authors:  Andreas Peth; Henrike C Besche; Alfred L Goldberg
Journal:  Mol Cell       Date:  2009-12-11       Impact factor: 17.970

7.  Isolation of mammalian 26S proteasomes and p97/VCP complexes using the ubiquitin-like domain from HHR23B reveals novel proteasome-associated proteins.

Authors:  Henrike C Besche; Wilhelm Haas; Steven P Gygi; Alfred L Goldberg
Journal:  Biochemistry       Date:  2009-03-24       Impact factor: 3.162

Review 8.  Recognition and processing of ubiquitin-protein conjugates by the proteasome.

Authors:  Daniel Finley
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Ubiquitin depletion as a key mediator of toxicity by translational inhibitors.

Authors:  John Hanna; David S Leggett; Daniel Finley
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  Enhancement of proteasome activity by a small-molecule inhibitor of USP14.

Authors:  Byung-Hoon Lee; Min Jae Lee; Soyeon Park; Dong-Chan Oh; Suzanne Elsasser; Ping-Chung Chen; Carlos Gartner; Nevena Dimova; John Hanna; Steven P Gygi; Scott M Wilson; Randall W King; Daniel Finley
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

View more
  5 in total

1.  USP14 inhibitor attenuates cerebral ischemia/reperfusion-induced neuronal injury in mice.

Authors:  Jia-Wei Min; Lanhai Lü; Jessica L Freeling; Doug S Martin; Hongmin Wang
Journal:  J Neurochem       Date:  2017-01-26       Impact factor: 5.372

Review 2.  Meddling with Fate: The Proteasomal Deubiquitinating Enzymes.

Authors:  Stefanie A H de Poot; Geng Tian; Daniel Finley
Journal:  J Mol Biol       Date:  2017-10-05       Impact factor: 5.469

3.  An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons.

Authors:  Monica Boselli; Byung-Hoon Lee; Jessica Robert; Miguel A Prado; Sang-Won Min; Chialin Cheng; M Catarina Silva; Changhyun Seong; Suzanne Elsasser; Ketki M Hatle; Timothy C Gahman; Steven P Gygi; Stephen J Haggarty; Li Gan; Randall W King; Daniel Finley
Journal:  J Biol Chem       Date:  2017-09-26       Impact factor: 5.157

4.  Allosteric control of Ubp6 and the proteasome via a bidirectional switch.

Authors:  Sven Klumpe; Markus R Eisele; Suzanne Elsasser; Geng Tian; Ka Ying Sharon Hung; Shuangwu Sun; Jamie A Moroco; Tat Cheung Cheng; Tapan Joshi; Timo Seibel; Duco Van Dalen; Xin-Hua Feng; Ying Lu; Huib Ovaa; John R Engen; Byung-Hoon Lee; Till Rudack; Eri Sakata; Daniel Finley
Journal:  Nat Commun       Date:  2022-02-11       Impact factor: 14.919

5.  Poly-Ub-substrate-degradative activity of 26S proteasome is not impaired in the aging rat brain.

Authors:  Carolin Giannini; Alexander Kloß; Sabrina Gohlke; Michele Mishto; Thomas P Nicholson; Paul W Sheppard; Peter-Michael Kloetzel; Burkhardt Dahlmann
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.